Deals this week: Valeant Pharmaceuticals International, Novan, Recursion Pharmaceuticals
Valeant Pharmaceuticals International plans to raise C$1bn ($801.37m) through the private placement of senior secured notes. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news
Modifying MDI Canister Surfaces to Improve Drug Stability and Delivery
Hydrofluoroalkane (HFA) based propellants are widely used in modern metered-dose inhalers (MDI) due to their lack of hazardous and environmentally damaging effects. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news
H & T Presspart to Showcase Respiratory Drug Delivery Devices at CPhi Worldwide
H&T Presspart will be exhibiting at this year's CPhi Worldwide exhibition in Frankfurt. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news
Aptar Pharma to Attend CPhI Worldwide, Germany
Aptar Pharma has announced it will be a main exhibitor at CPhI Worldwide. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news
Janssen submits sNDA to FDA for Invokana to reduce risk of MACE
Janssen Research and Development has submitted a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for Invokana (canagliflozin) to reduce the risk of major adverse cardiovascular events (MACE). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 4, 2017 Category: Pharmaceuticals Source Type: news
NIH funds neonatal opioid withdrawal syndrome study
The US National Institutes of Health (NIH) is funding a new study to investigate treatment options for neonatal opioid withdrawal syndrome. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 4, 2017 Category: Pharmaceuticals Source Type: news
HHS and Regeneron to develop therapeutics for influenza and emerging pathogens
The US Department of Health and Human Services ’ Office of the Assistant Secretary for Preparedness and Response (ASPR) has partnered with Regeneron Pharmaceuticals to develop new therapeutics to treat influenza and emerging infectious diseases. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 4, 2017 Category: Pharmaceuticals Source Type: news
How voice assistant technology could revolutionise clinical trials
A new research collaboration aims to improve both data collection and patient engagement in clinical trials by harnessing the power of voice recognition. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 4, 2017 Category: Pharmaceuticals Source Type: news
Case Study: Packaging and Distribution in the Asia-Pacific
The globalisation and changing regulations of clinical trials has led to the inclusion of many Asia-Pacific countries in the portfolio of target countries for clinical trials today. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 4, 2017 Category: Pharmaceuticals Source Type: news
US FDA approves Takeda ’s sNDA for new dose regimen of Alunbrig 180mg tablets
The US Food and Drug Administration (FDA) has approved Takeda Pharmaceutical Company ’s supplemental new drug application (sNDA) for 180mg Alunbrig tablets to treat patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lun… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 3, 2017 Category: Pharmaceuticals Source Type: news
Gilead Sciences buys US firm Kite Pharma for $11.9bn
Biopharmaceutical company Gilead Sciences has completed the acquisition of US-based Kite Pharma for approximately $11.9bn. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 3, 2017 Category: Pharmaceuticals Source Type: news
Pfizer ’s CTI and ADDF to co-fund new project to treat neurodegenerative diseases
The Alzheimer ’s Drug Discovery Foundation (ADDF) and Pfizer’s Centers for Therapeutic Innovation (CTI) will jointly fund a new project that seeks to develop potential treatments for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 3, 2017 Category: Pharmaceuticals Source Type: news
Protection and Performance: Polypropylene Products
Salare's Maelstrom is a low-maintenance, point-of-use, compact wet scrubber specifically designed for function within the Fume Hood. It is non-corrosive, durable, easy-to-maintain, and weldable. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 3, 2017 Category: Pharmaceuticals Source Type: news
Zenith's Director of Global Managed Services David Staunton
Zenith Technologies has appointed David Staunton as director of global managed services to help meet increased demand for its automation and manufacturing execution system (MES) services. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 3, 2017 Category: Pharmaceuticals Source Type: news
Meet NSF at Pharma Integrates, London
After the success of the 2016 conference, NSF International is pleased to be exhibiting again at Pharma Integrates 2017. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 3, 2017 Category: Pharmaceuticals Source Type: news
